{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T14:23:29Z","timestamp":1789395809554,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.jns.2009.11.013","type":"journal-article","created":{"date-parts":[[2010,1,15]],"date-time":"2010-01-15T00:55:01Z","timestamp":1263516901000},"page":"41-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Methionine sulfoximine, an inhibitor of glutamine synthetase, lowers brain glutamine and glutamate in a mouse model of ALS"],"prefix":"10.1016","volume":"290","author":[{"given":"Farhad","family":"Ghoddoussi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew P.","family":"Galloway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amruta","family":"Jambekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Bame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Needleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William S.A.","family":"Brusilow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jns.2009.11.013_bib1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/archneur.58.3.365","article-title":"Glutamate transporters in neurologic disease","volume":"58","author":"Maragakis","year":"2001","journal-title":"Arch Neurol"},{"issue":"4","key":"10.1016\/j.jns.2009.11.013_bib2","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/mus.10186","article-title":"Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis","volume":"26","author":"Heath","year":"2002","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2009.11.013_bib3","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1146\/annurev.neuro.27.070203.144244","article-title":"Unraveling the mechanisms involved in motor neuron degeneration in ALS","volume":"27","author":"Bruijn","year":"2004","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.jns.2009.11.013_bib4","first-page":"1","article-title":"Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole","volume":"30","author":"Banasr","year":"2008","journal-title":"Mol Psychiatry"},{"issue":"Pt 8","key":"10.1016\/j.jns.2009.11.013_bib5","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1093\/brain\/awn133","article-title":"Recurrent seizures and brain pathology after inhibition of glutamine synthetase in the hippocampus in rats","volume":"131","author":"Eid","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.jns.2009.11.013_bib6","first-page":"7","article-title":"Excitotoxic mechanisms in the pathogenesis of amyotrophic lateral sclerosis","volume":"68","author":"Rothstein","year":"1995","journal-title":"Adv Neurol"},{"issue":"Suppl 2","key":"10.1016\/j.jns.2009.11.013_bib7","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1007\/BF03160574","article-title":"Glutamate, excitotoxicity and amyotrophic lateral sclerosis","volume":"244","author":"Shaw","year":"1997","journal-title":"J Neurol"},{"issue":"9","key":"10.1016\/j.jns.2009.11.013_bib8","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1517\/17425255.4.9.1223","article-title":"Riluzole in psychiatry: a systematic review of the literature","volume":"4","author":"Zarate","year":"2008","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"1","key":"10.1016\/j.jns.2009.11.013_bib9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1471-4159.2006.04200.x","article-title":"Measurements of the anaplerotic rate in the human cerebral cortex using 13C magnetic resonance spectroscopy and [1-13C] and [2-13C] glucose","volume":"100","author":"Mason","year":"2007","journal-title":"J Neurochem"},{"issue":"5","key":"10.1016\/j.jns.2009.11.013_bib10","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1523\/JNEUROSCI.22-05-01523.2002","article-title":"Astroglial contribution to brain energy metabolism in humans revealed by 13C nuclear magnetic resonance spectroscopy: elucidation of the dominant pathway for neurotransmitter glutamate repletion and measurement of astrocytic oxidative metabolism","volume":"22","author":"Lebon","year":"2002","journal-title":"J Neurosci"},{"issue":"3","key":"10.1016\/j.jns.2009.11.013_bib11","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1471-4159.1974.tb06046.x","article-title":"Fate of L-glutamate in the brain","volume":"23","author":"Benjamin","year":"1974","journal-title":"J Neurochem"},{"issue":"4","key":"10.1016\/j.jns.2009.11.013_bib12","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/(SICI)1097-4547(19990815)57:4<417::AID-JNR1>3.0.CO;2-N","article-title":"Astrocytes: glutamate producers for neurons","volume":"57","author":"Hertz","year":"1999","journal-title":"J Neurosci Res"},{"issue":"3","key":"10.1016\/j.jns.2009.11.013_bib13","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1046\/j.1471-4159.2001.00322.x","article-title":"Transfer of glutamine between astrocytes and neurons","volume":"77","author":"Broer","year":"2001","journal-title":"J Neurochem"},{"issue":"6415","key":"10.1016\/j.jns.2009.11.013_bib14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/362059a0","article-title":"Mutations in Cu\/Zn Superoxide-Dismutase Gene Are Associated with Familial Amyotrophic-Lateral-Sclerosis","volume":"362","author":"Rosen","year":"1993","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.jns.2009.11.013_bib15","first-page":"303","article-title":"Mutations in the Cu-Zn Superoxide-Dismutase Gene in Familial Amyotrophic-Lateral-Sclerosis","volume":"34","author":"Siddique","year":"1993","journal-title":"Ann Neurol"},{"issue":"5166","key":"10.1016\/j.jns.2009.11.013_bib16","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1126\/science.8209258","article-title":"Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation","volume":"264","author":"Gurney","year":"1994","journal-title":"Science"},{"issue":"21","key":"10.1016\/j.jns.2009.11.013_bib17","doi-asserted-by":"crossref","first-page":"6674","DOI":"10.1016\/S0021-9258(17)32998-8","article-title":"Enzymatic reactions of methionine sulfoximine. Conversion to the corresponding alpha-imino and alpha-keto acids and to alpha-ketobutyrate and methane sulfinimide","volume":"251","author":"Cooper","year":"1976","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.jns.2009.11.013_bib18","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1161\/01.STR.21.2.322","article-title":"Methionine sulfoximine reduces cortical infarct size in rats after middle cerebral artery occlusion","volume":"21","author":"Swanson","year":"1990","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.jns.2009.11.013_bib19","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/j.1471-4159.1990.tb01956.x","article-title":"Comparison of transmitter amino acid levels in rat globus pallidus and neostriatum during hypoglycemia or after treatment with methionine sulfoximine or gamma-vinyl gamma-aminobutyric acid","volume":"54","author":"Fonnum","year":"1990","journal-title":"J Neurochem"},{"issue":"2\u20133","key":"10.1016\/j.jns.2009.11.013_bib20","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0304-3940(90)90478-R","article-title":"Chronic methionine sulfoximine administration reduces synaptosomal aspartate and glutamate in rat striatum","volume":"115","author":"Somers","year":"1990","journal-title":"Neurosci Lett"},{"issue":"2","key":"10.1016\/j.jns.2009.11.013_bib21","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0306-4522(94)90249-6","article-title":"Glutamate in some retinal neurons is derived solely from glia","volume":"60","author":"Pow","year":"1994","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.jns.2009.11.013_bib22","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1046\/j.1471-4159.1995.65020871.x","article-title":"Glutamine from glial cells is essential for the maintenance of the nerve terminal pool of glutamate: immunogold evidence from hippocampal slice cultures","volume":"65","author":"Laake","year":"1995","journal-title":"J Neurochem"},{"issue":"10","key":"10.1016\/j.jns.2009.11.013_bib23","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1111\/j.1530-0277.2008.00747.x","article-title":"Neonatal alcohol-induced region-dependent changes in rat brain neurochemistry measured by high-resolution magnetic resonance spectroscopy","volume":"32","author":"O'Leary-Moore","year":"2008","journal-title":"Alcohol Clin Exp Res"},{"issue":"10","key":"10.1016\/j.jns.2009.11.013_bib24","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1038\/npp.2009.58","article-title":"Glutaminase-deficient mice display hippocampal hypoactivity, insensitivity to pro-psychotic drugs and potentiated latent inhibition: relevance to schizophrenia","volume":"34","author":"Gaisler-Salomon","year":"2009","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.jns.2009.11.013_bib25","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/nbm.1352","article-title":"Cardiac effects of MDMA on the metabolic profile determined with 1H-magnetic resonance spectroscopy in the rat","volume":"22","author":"Perrine","year":"2009","journal-title":"NMR Biomed"},{"key":"10.1016\/j.jns.2009.11.013_bib26","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0076-6879(85)13030-2","article-title":"Glutamine synthetase from mammalian tissues","volume":"113","author":"Meister","year":"1985","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.jns.2009.11.013_bib27","series-title":"The mouse brain in stereotaxic coordinates","author":"Franklin","year":"2008"},{"issue":"12","key":"10.1016\/j.jns.2009.11.013_bib28","doi-asserted-by":"crossref","first-page":"6408","DOI":"10.1073\/pnas.94.12.6408","article-title":"Quantitative neuropathology by high resolution magic angle spinning proton magnetic resonance spectroscopy","volume":"94","author":"Cheng","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.jns.2009.11.013_bib29","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/mrm.1910300604","article-title":"Estimation of metabolite concentrations from localized in vivo proton NMR spectra","volume":"30","author":"Provencher","year":"1993","journal-title":"Magn Reson Med"},{"issue":"3","key":"10.1016\/j.jns.2009.11.013_bib30","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1021\/bi00831a038","article-title":"Studies on the mechanism of inhibition of glutamine synthetase by methionine sulfoximine","volume":"8","author":"Ronzio","year":"1969","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.jns.2009.11.013_bib31","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/jn\/45.3.451","article-title":"The relative effect of methionine sulfoximine on different animal species","volume":"45","author":"Gershoff","year":"1951","journal-title":"J Nutr"},{"issue":"1","key":"10.1016\/j.jns.2009.11.013_bib32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0361-9230(01)00631-1","article-title":"Chronic inhibition of glutamine synthetase is not associated with impairment of learning and memory in mice","volume":"57","author":"Blin","year":"2002","journal-title":"Brain Res Bull"},{"issue":"12","key":"10.1016\/j.jns.2009.11.013_bib33","doi-asserted-by":"crossref","first-page":"4982","DOI":"10.1016\/S0021-9258(18)50550-0","article-title":"The metabolic fate of 13N-labeled ammonia in rat brain","volume":"254","author":"Cooper","year":"1979","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jns.2009.11.013_bib34","series-title":"Glutamine, Glutamate, and GABA in the Central Nervous System","first-page":"77","article-title":"Cerebral Glutamine Synthetase","author":"Cooper","year":"1983"},{"issue":"2\u20133","key":"10.1016\/j.jns.2009.11.013_bib35","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.neuint.2003.08.014","article-title":"Cerebral glucose metabolism and the glutamine cycle as detected by in vivo and in vitro 13C NMR spectroscopy","volume":"45","author":"Garcia-Espinosa","year":"2004","journal-title":"Neurochem Int"},{"issue":"34","key":"10.1016\/j.jns.2009.11.013_bib36","doi-asserted-by":"crossref","first-page":"9192","DOI":"10.1523\/JNEUROSCI.1198-07.2007","article-title":"Excitatory synaptic transmission persists independently of the glutamate-glutamine cycle","volume":"27","author":"Kam","year":"2007","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.jns.2009.11.013_bib37","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuron.2006.02.022","article-title":"High-density presynaptic transporters are required for glutamate removal from the first visual synapse","volume":"50","author":"Hasegawa","year":"2006","journal-title":"Neuron"},{"issue":"17","key":"10.1016\/j.jns.2009.11.013_bib38","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1523\/JNEUROSCI.4241-05.2006","article-title":"Mice lacking brain\/kidney phosphate-activated glutaminase have impaired glutamatergic synaptic transmission, altered breathing, disorganized goal-directed behavior and die shortly after birth","volume":"26","author":"Masson","year":"2006","journal-title":"J Neurosci"},{"issue":"4","key":"10.1016\/j.jns.2009.11.013_bib39","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1177\/1073858406289639","article-title":"Is Huntington's a glutamine storage disease?","volume":"12","author":"Brusilow","year":"2006","journal-title":"Neuroscientist"},{"issue":"Pt 4","key":"10.1016\/j.jns.2009.11.013_bib40","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/brain\/awh428","article-title":"[11C]-WAY100635 PET demonstrates marked 5-HT1A receptor changes in sporadic ALS","volume":"128","author":"Turner","year":"2005","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.jns.2009.11.013_bib41","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1080\/00207450600754087","article-title":"Serotonergic mechanisms in amyotrophic lateral sclerosis","volume":"116","author":"Sandyk","year":"2006","journal-title":"Int J Neurosci"},{"issue":"1","key":"10.1016\/j.jns.2009.11.013_bib42","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1471-4159.1975.tb07628.x","article-title":"Effect of methionine and methionine sulphoximine on rat brain S-adenosyl methionine levels","volume":"24","author":"Schatz","year":"1975","journal-title":"J Neurochem"},{"issue":"2","key":"10.1016\/j.jns.2009.11.013_bib43","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0006-8993(01)03015-3","article-title":"Glutamine is the major precursor for GABA synthesis in rat neocortex in vivo following acute GABA-transaminase inhibition","volume":"919","author":"Patel","year":"2001","journal-title":"Brain Res"},{"issue":"10","key":"10.1016\/j.jns.2009.11.013_bib44","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1001\/archneur.63.10.1372","article-title":"Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterations","volume":"63","author":"Lewis","year":"2006","journal-title":"Arch Neurol"},{"issue":"7021","key":"10.1016\/j.jns.2009.11.013_bib45","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nature03180","article-title":"Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression","volume":"433","author":"Rothstein","year":"2005","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.jns.2009.11.013_bib46","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.nbd.2005.08.014","article-title":"Selective up-regulation of the glial Na+-dependent glutamate transporter GLT1 by a neuroimmunophilin ligand results in neuroprotection","volume":"21","author":"Ganel","year":"2006","journal-title":"Neurobiol Dis"},{"issue":"9","key":"10.1016\/j.jns.2009.11.013_bib47","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1111\/j.1460-9568.2005.04431.x","article-title":"Memantine prolongs survival in an amyotrophic lateral sclerosis mouse model","volume":"22","author":"Wang","year":"2005","journal-title":"Eur J Neurosci"},{"issue":"5","key":"10.1016\/j.jns.2009.11.013_bib48","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000090364","article-title":"Celastrol blocks neuronal cell death and extends life in transgenic mouse model of amyotrophic lateral sclerosis","volume":"2","author":"Kiaei","year":"2005","journal-title":"Neurodegener Dis"},{"issue":"2","key":"10.1016\/j.jns.2009.11.013_bib49","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1471-4159.2005.03024.x","article-title":"Integrative role of cPLA with COX-2 and the effect of non-steriodal anti-inflammatory drugs in a transgenic mouse model of amyotrophic lateral sclerosis","volume":"93","author":"Kiaei","year":"2005","journal-title":"J Neurochem"},{"issue":"7","key":"10.1016\/j.jns.2009.11.013_bib50","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1111\/j.1460-9568.2007.05471.x","article-title":"Recombinant human erythropoietin suppresses symptom onset and progression of G93A-SOD1 mouse model of ALS by preventing motor neuron death and inflammation","volume":"25","author":"Koh","year":"2007","journal-title":"Eur J Neurosci"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X09009769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X09009769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:40:18Z","timestamp":1758382818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X09009769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":50,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0022510X09009769"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2009.11.013","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methionine sulfoximine, an inhibitor of glutamine synthetase, lowers brain glutamine and glutamate in a mouse model of ALS","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2009.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}